Chat with us, powered by LiveChat Provide FDA Indication (include stages), neurotransmitters Affected/Mechanism of Action, and Target Symptoms. Include formulation (Short-acting, intermediate-acting, or long-acting), - Writingforyou

Provide FDA Indication (include stages), neurotransmitters Affected/Mechanism of Action, and Target Symptoms. Include formulation (Short-acting, intermediate-acting, or long-acting),

  

  1. For each medication listed, complete the following:
    1. Provide FDA Indication (include stages), neurotransmitters Affected/Mechanism of Action, and Target Symptoms.
    2. Include formulation (Short-acting, intermediate-acting, or long-acting), duration of action,  half-life, and CYP 450 enzyme information.
    3. List notable side effects and precautions.
    4. Include Patient Education Instructions.

please make sure Font is consistent throughout table, and grammar, spelling, and/or punctuation are accurate.

A total of 4 references needed with intext citation. 2 references provided below. Please use 7th edition APA scholarly references that are witin 5 years.

Stahl, S.M. (2020). Stahl’s essential psychopharmacology: Prescribers guide (7th ed.). Cambridge University Press.

Stahl, S. M. (2021). Stahl’s essential psychopharmacology: Neuroscientific basis and practical applications (5th ed.). Cambridge University Press.

Drug Name and Class

FDA Indication (include stages )

Neurotransmitters Affected/Mechanism of Action

Target Symptoms

Short-acting, intermediate-acting, or long-acting.

Duration of Action and Half-life (T1/2),

CYP 450 enzyme

Notable Side Effects/Precautions /Patient Education Instructions

Donepezil (Aricept)

Rivastigmine (Exelon)

Galantamine (Razadyne, Razadyne ER)

Memantine (Namenda)